Abstract
The Netherlands breast cancer screening programme for women aged 50–75 years was gradually implemented during 1989–1997. Short-term indicators for this mammography screening are 80% attendance (800000 examinations yearly), and for the subsequent screening examinations 7.4 referrals for clinical assessment per 1000 women screened, 4.7 biopsies and 3.6 breast cancers detected. Breast cancer mortality in The Netherlands has been decreasing since 1997 after having been stable for decades. The challenge now is to disentangle the relative contributions of mammographic screening, earlier clinical diagnosis, less aggressive tumours, treatment advances and risk factors towards this decline.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
